Table 2 Summary of all 15 cases
Case | Result of preoperative CNB | Final pathology | Method of surgery | Chemotherapy | Radiotherapy | Endocrine therapy | Follow-up (months) | Recurrence |
|---|---|---|---|---|---|---|---|---|
1 | IDP | AME carcinoma | WLE | − | + | Tamoxifen | 105 | − |
2 | IDC | AME carcinoma with DCIS | BCS, SLNB | − | + | 105 | − | |
3 | AME tumor | AME carcinoma | TM, SLNB | Adjuvant AC 4 cycles | − | 72 | − | |
4 | AME carcinoma | AME carcinoma | WLE, SLNB | Adjuvant TAC 6 cycles | + | 37 | − | |
5 | AME neoplasm | AME carcinoma | WLE | − | + | 33 | − | |
6 | Eccrine spiradenoma | AME carcinoma | WLE | − | − | 20 | − | |
7 | Papillary neoplasm | AME carcinoma | WLE, SLNB | − | + | Tamoxifen | 14 | − |
8 | AME carcinoma | AME carcinoma | WLE | − | + | Tamoxifen | 8 | − |
9 | IDC | AME carcinoma | BCS, SLNB | − | + | 54 | − | |
10 | Papillary neoplasm | AME carcinoma | WLE | − | + | Tamoxifen | 45 | − |
11 | AME neoplasm | AME carcinoma | WLE | − | + | 33 | − | |
12 | AME neoplasm | AME carcinoma | WLE | − | + | 162 | Local recurrence, lung metastasis | |
13 | Sclerosing adenosis | AME carcinoma | WLE | − | − | 111 | − | |
14 | Papillary neoplasm | AME carcinoma | WLE | − | − | 5 | − | |
15 | IDC | AME carcinoma | TM, SLNB | Neoadjuvant AC 4 cycles | − | Tamoxifen | 24 | Lung metastasis |